As Mirena Lawsuits Move Forward, Bernstein Liebhard LLP Notes Doubling of IUD Use Over Past Five Years

Share Article

Findings come amid the filing of thousands of Mirena IUD lawsuits in U.S. courts on behalf of women who allegedly suffered serious complications due to spontaneous migration of the device.

Free Case Review
The publication of this report comes as thousands of women are pursuing Mirena IUD lawsuits for serious complications they allegedly sustained due to its use.

As Mirena lawsuits (http://www.mirenalawsuit2014.com/) continue to move forward in courts around the U.S., Bernstein Liebhard LLP notes new data suggesting that it and other IUDs are becoming an increasingly-popular birth control choice for many young women. According to HealthDay News, a recent report published by the U.S. National Center for Health Statistics revealed that IUD use has nearly doubled in the last five years. From 2006 through 2010, just 3.5% of women chose to use Mirena or another IUD as their primary method of birth control. But between 2011 and 2013, the rate grew to 6.4%.*

The authors of the report attributed the growing popularity of IUDs to new guideline issued by major health organizations over the past several years that now recommend the device for younger women. For example, HealthDay News pointed out that the American Academy of Pediatrics now recommends IUDs as a first option for teen girls.

“The publication of this report comes as thousands of women are pursuing Mirena IUD lawsuits for serious complications they allegedly sustained due to its use. It is important that any young woman considering Mirena as her method of birth control be fully apprised of its potential risks,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is currently offering free case evaluations to women who were allegedly harmed after their Mirena IUD spontaneously migrated from its proper position in the uterus.

Mirena IUD Lawsuits
The Mirena IUD was first cleared for sale by the U.S. Food & Drug Administration (FDA) in 2000 as a method of birth control. In 2009, the agency expanded Mirena’s approved uses to include the prevention of heavy menstrual bleeding in women who wish to use an IUD as their primary method of birth control.** Later that same year, the FDA issued a Warning Letter to Bayer Healthcare Pharmaceuticals after finding that one of the company’s Mirena promotions made misleading claims about the safety and efficacy of the IUD.

According to court documents, nearly 1,300 Mirena lawsuits are currently pending in New Jersey’s Bergen County Superior Court, where Bernstein Liebhard LLP is actively filing claims. (In Re: Mirena Litigation; Case No. 297) More than 1,000 additional lawsuits have been filed in a federal multidistrict litigation established in the U.S. District Court, Southern District of New York. (In re: Mirena IUD Products Liability Litigation, MDL No. 2434)

Court records indicate that all of these Mirena plaintiffs accuse Bayer Healthcare Pharmaceuticals of failing to warn that the device might migrate even after being properly inserted into the uterus by a healthcare provider, and point out that the product’s label only cautions that migration might occur if the uterus is perforated when the IUD is being implanted. They also claim that the company has a history of overstating the benefits purportedly associated with Mirena, and of downplaying the risk for serious complications.

Women who allegedly suffered serious injuries due to spontaneous Mirena migration may be entitled to take legal action against Bayer Healthcare Pharmaceuticals. To learn more about filing a Mirena lawsuit, please visit Bernstein Liebhard LLP’s website, or the Firm’s Facebook page: https://www.facebook.com/mirenalawsuithelp. For a free legal consultation, please call 800-511-5092.

*consumer.healthday.com/women-s-health-information-34/birth-control-news-62/pill-remains-most-common-method-of-contraception-report-shows-694485.html, HealthDay News, December 11, 2014
**http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/021225s027lbl.pdf, FDA 2009

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs’ Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
800-511-5092

ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info (at) consumerinjurylawyers (dot) com
http://www.mirenalawsuit2014.com/
https://plus.google.com/115936073311125306742?rel=author

Share article on socal media or email:

View article via:

Pdf Print

Contact Author

Felecia L. Stern
Visit website